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Helicobacter pylori is a human pathogen and can lead to 
chronic gastritis, peptic ulcer disease, gastric adenocarcinoma 
and mucosa-associated lymphoid tissue lymphoma. H. pylori 
infection is associated with gastric cancer and has been cat-
egorized as a group I carcinogen in gastric cancer. In 2016, 
Maastricht V/Florence Consensus report emphasized H. pylori 
infection as an infectious disease and reinforced the statement 
that H. pylori eradication can cure gastritis and alter the pro-
gression to long-term complications, or recurrence of disease.1,2 
Thus, screening and eradication for H. pylori is recommended in 
individuals at increased risk for gastric cancer. 
Although H. pylori eradication after gastric cancer surgery is 
also recommended,1,3 it was not clear that eradication therapy 
could reduce the risk of metachronous gastric cancer in the 
remnant stomach after partial gastrectomy. A recent prospective 
randomized clinical trial in Korea reported that gastric cancer 
recurrence rate was not different according to H. pylori eradica-
tion treatment (5-year gastric cancer recurrence rates, 4.6% in 
the treatment group vs 8.5% in the placebo group; p=0.652).4 In 
this kind of study, it is necessary to be able to control or elimi-
nate influences by the timing of eradication, intragastric envi-
ronmental change due to gastrectomy and spontaneous regres-
sion of H. pylori infection in order to confirm the effectiveness 
of the eradication treatment.
There are a several things to consider when deciding to treat. 
The first is the time of eradication. Postoperative eradication 
therapy is preferred to preoperative eradication therapy because 
of several reasons in clinics. Additional 1 or 2 weeks is needed 
for the eradication therapy before surgery. Adverse events as-
sociated with antibiotics may occur and delay the surgery. In 
cases with unplanned total gastrectomy, eradication therapy 
would not be unnecessary. The second is that even if eradica-
tion was not tried, H. pylori can spontaneously disappear.3 In 
general, H. pylori infection persists if not eradicated, whereas 
the spontaneous regression is happened in the remnant stom-
ach. The overall spontaneous clearance rate of H. pylori infec-
tion after partial gastrectomy was reported 38.6% to 43%.4,5 
Previous study reported that the spontaneous clearance rate of 
H. pylori was related to operative procedures.6 The Billroth-II 
procedure had a higher bile reflux rate and a lower H. pylori in-
fection prevalence than the Billroth-I procedure. Bile reflux is a 
pathogenic factor in gastric remnant reflux gastritis and induces 
chronic histological inflammation.7 Third, if you decide to treat, 
we have to decide to re-test postoperative status of H. pylori. It 
was assumed that the change of pH and bile reflux in the rem-
nant stomach might affect H. pylori colonization.5,8,9 Hypochlor-
hydric environment caused by antrectomy and increased bile 
reflux due to the loss of pyloric ring might inhibit the growth 
of H. pylori. And rate of H. pylori infection decreased over time 
after partial gastrectomy. A study in Taiwan reported the preva-
lence of H. pylori 1 to 15 years after surgery was 29.5%, after 
16 to 30 years it was 13.6%, and after more than 30 years it 
was 10%.9 However, studies on how H. pylori infections change 
after gastrectomy are still lacking.
The article published in Gut and Liver, “Dynamic changes in 
Helicobacter pylori status following gastric cancer surgery” by 
Yoon et al.10 started from a question for clinicians about the 
need for retest postoperative H. pylori status. In this study, they 
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evaluated the postoperative changes of H. pylori detection and 
analyzed the factors which affect changes of in H. pylori infec-
tion status after gastric cancer surgery. One hundred forty pa-
tients who underwent curative gastrectomy and had a positive H. 
pylori status without eradication therapy at the time of gastric 
cancer diagnosis were prospectively enrolled and annual follow-
up was done to evaluate postoperative H. pylori status. The rate 
of spontaneous negative conversion at least once during follow-
up was 42.9% (60/140). And of these 60 patients, eight (13.3%) 
showed more complex postoperative dynamic changes between 
negative and positive results after being confirmed as spontane-
ous negative conversion. The author analyzed factors associated 
with H. pylori status and demonstrated that the spontaneous 
negative conversion group showed a trend of more postopera-
tive intestinal metaplasia compared to the persistent H. pylori 
group (36.7% [22/60] vs 16.3% [13/80], p=0.001). Unlike other 
previous study,11 there was no significant difference between 
spontaneous conversion and persistently positive groups ac-
cording to the surgery type which could affect the bile reflux. 
The peculiarities of this study were that the intestinal metaplasia 
of the remnant stomach had a greater effect on the presence of 
H. pylori than bile reflux which can be affected by types of sur-
gery. The author demonstrated that these results could suggest 
that intestinal metaplasia could be a more important factor for 
the survival of H. pylori than bile reflux. However, this finding 
needs to be confirmed by further studies.
The present study showed that there was relatively high per-
centage of spontaneous regression and dynamic changes in 
status of H. pylori after partial gastrectomy, in case of more his-
tologic intestinal metaplasia in the remnant stomach in postop-
erative period. Inaccurate diagnosis for status of H. pylori may 
lead to unnecessary eradication therapy and underestimate the 
protective effect of eradication therapy in patients with gastric 
cancer surgery. This clinical evidence could support a need to 
retest of postoperative H. pylori status before eradication thera-
py. However, it still cannot give answer as to how and when to 
test H. pylori after gastrectomy, more research is needed. 
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